idarubicin and its Impurities
The compound has shown activity against breast cancer, lymphomas and leukemias, together with the potential for reduced cardiac toxicity. An orally administered anthracycline antineoplastic.Reference standards of Idarubicin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
(7S,9S)-9-Acetyl-7-(((2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,9,11-trihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione
(7S,9S)-9-Acetyl-7-(((2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,9,11-trihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione
Catalogue No.:PA 09 0311002
CAS :
58957-93-0
Molecular Formula : C26H27NO9
Molecular Weight : 497.5
